Nkarta Share Price

Nkarta Share Price

NASDAQ: NKTX | Micro Cap | Healthcare
$1.20
-$0.05 (-4%) Last updated on 19 Nov, 2026 | 01:21 IST
  • Performance
  • Chart
  • Fundamentals
  • Profit & Loss
  • Balance Sheet
  • Cash Flow
  • About
  • Price history
  • FAQs

Nkarta Stock Performance

Open
$1.25
Prev. Close
$1.25
Circuit Range
N/A
Day Range
$1.18 - $1.26
Year Range
$1.10 - $3.71
Volume
19,977
Average Traded
$1.21

Nkarta Share Price Today

As of 19 November 2026, Nkarta, Inc.'s share price is $1.20. The stock opened at $1.25, compared to its previous close of $1.25. During today's trading session, Nkarta, Inc.'s share price traded between $1.18 and $1.26, with an average price of $1.22. Over the past 52 weeks, the stock has recorded a high of $3.71 and a low of $1.10. In terms of performance, Nkarta, Inc.'s share price has declined by 62.85% over the last six months and is down 36.51% on a year-on-year basis.

Nkarta Share Price Chart

Line chart of the Nkarta price trend over the selected period. The price fell overall, ranging from 1.18 to 1.26, ending at 1.20.
$1.18$1.26
L
Show Current Price
H

Nkarta Stock Fundamentals & Key Indicators

Market Cap
$88.79M
PE Ratio (TTM)
N/A
Dividend Yield
0.00%
EPS (TTM)
$-1.81
Revenue (TTM)
$0.00
Return On Equity (TTM)
-60.01%
Profit Margin
N/A
Debt to Equity
0.00
Quarterly Earnings Growth YoY
-21.60%

Nkarta Quarterly Profit & Loss

All figures in USD

ParticularsDec 2025Mar 2026Jun 2026Sep 2026
Revenue$0.00$0.00$0.00$0.00
Net Profit-$27.41-$28.37-$40.37-$33.33
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.50%-42.30%17.44%

Nkarta Annual Profit & Loss

All figures in USD

Particulars2022202320242025
Revenue$0.00$0.00$0.00$0.00
Net Profit-$113.84-$117.50-$108.79-$104.08
Net Profit MarginN/AN/AN/AN/A
Income ChangeN/A-3.22%7.41%4.33%

Nkarta Balance Sheet

All figures in USD Million

Particulars2025202420232022
Non Current Assets121.7227.87125.81112.25
Current Assets282.51273.34253.07360.69
Total Assets404.21501.2378.89472.94
Non Current Liabilities69.6274.3182.2778.69
Current Liabilities22.2718.9223.3322.05
Total Liabilities91.8893.23105.6100.73
Shareholders' Equity312.33407.98273.29372.21

Nkarta Cash Flow

Annually

All figures in USD Million

Particulars2025202420232022
Operating-88.7-99.7-86.16-57.0
Investing100.32-129.5679.02-184.69
Financing0.14226.080.69219.01

About Nkarta

Nkarta Inc is a clinical-stage biopharmaceutical company pioneering the development of allogeneic, off-the-shelf engineered natural killer (NK) cell therapies. The company is engaged in leveraging the natural potent power of NK cells to identify and kill abnormal cells and recruit adaptive immune effectors to generate responses that are specific and durable. The company is combining its NK-cell expansion platform technology with proprietary cell engineering technologies to generate an abundant supply of NK cells, engineer enhanced NK cell recognition of therapeutic targets, and improve persistence for sustained activity in the body for the treatment of cancer.

Nkarta Historical Returns

Share price history by day, with open and close prices and the day's change
MonthOpenCloseChange %
Nov 2026
$1.61
$1.21
-23.00%
Oct 2026
$2.58
$1.56
-40.27%
Sep 2026
$2.64
$2.62
-4.73%
Aug 2026
$2.10
$2.75
+31.58%
Jul 2026
$2.81
$2.09
-25.75%
Jun 2026
$3.13
$2.81
-12.85%
May 2026
$2.78
$3.23
+16.19%
Apr 2026
$2.14
$2.78
+31.75%
Mar 2026
$2.67
$2.11
-21.71%
Feb 2026
$2.16
$2.69
+21.95%
Jan 2026
$1.85
$2.21
+19.78%
Dec 2025
$1.85
$1.84
-2.38%

Nkarta Share Price FAQs